You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

482 Results
Blog post
Dr. Edward Kucharski Among the many healthcare challenges facing trans and non-binary people, cancer poses a multi-edge threat. Not only are trans...
Nov 2019
Drug
Other Name(s): Unituxin®
Jun 2023
Guidelines and Advice
Status: Current
ID: GL 2-30a
Version: N/A
Mar 2020
Statistical Reports
This page is for drug manufacturers who need information on the cancer drug submission process. Please do not mail cancer drug submissions to Ontario...

Pages